title: Inhibitory effect of berberine on human skin squamous cell carcinoma A431 cells.
abstract: Berberine (BBR) is a natural alkaloid with significant anti-tumor activity against many types of cancer cells. In this study, we investigated the molecular mechanisms employed by BBR to repress the proliferation and growth of skin squamous cell carcinoma A431 cells. Berberine was reported to inhibit the proliferation of A431 cells in a dose- and time-dependent manner and was observed to induce a series of biochemical events, including the loss of mitochondrial membrane potential, release of cytochrome-c to cytosol, induction of proteins of the Bcl-2 family and caspases, and the cleavage of poly(ADP)-ribose polymerase. This suggested its ability to induce apoptosis. The results of a wound healing test revealed that berberine inhibited the migration of A431 cells. Ezrin was transfected into A431 cells by RNA interference. The level of expression of Ezrin in the transfected A431 cells was observed to decrease with berberine treatment, which suggested that berberine might inhibit the invasion of A431 cells through Ezrin. The results of this study demonstrated that berberine could potentially inhibit proliferation, induce apoptosis, and inhibit the invasion of A431 cells.
authors.affiliation: Department of Dermatology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot.
authors.forename: D X
authors.initials: DX
authors.lastname: Li
authors.affiliation: Department of Dermatology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot.
authors.forename: J
authors.initials: J
authors.lastname: Zhang
authors.affiliation: Medical College of Shandong University, Jinan, Shandong, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Zhang
authors.affiliation: Pathogenic Organisms and Immunology Lab, Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
authors.forename: P W
authors.initials: PW
authors.lastname: Zhao
authors.affiliation: Pathogenic Organisms and Immunology Lab, Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
authors.forename: L M
authors.initials: LM
authors.lastname: Yang
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D001599:Berberine / Q000494:pharmacology*; D053148:Caspase 3 / Q000235:genetics / Q000378:metabolism; D053453:Caspase 9 / Q000235:genetics / Q000378:metabolism; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D045304:Cytochromes c / Q000235:genetics / Q000378:metabolism; D003598:Cytoskeletal Proteins / Q000235:genetics* / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004847:Epithelial Cells / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D011065:Poly(ADP-ribose) Polymerases / Q000235:genetics / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction; D012867:Skin / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D019076:Transgenes; D051028:bcl-2-Associated X Protein / Q000235:genetics / Q000378:metabolism; D000099149:Ezrin
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D001599:Berberine; D053148:Caspase 3; D053453:Caspase 9; D045304:Cytochromes c; D003598:Cytoskeletal Proteins; D011065:Poly(ADP-ribose) Polymerases; D019253:Proto-Oncogene Proteins c-bcl-2; D051028:bcl-2-Associated X Protein; D000099149:Ezrin; C494826:BAX protein, human; C000595707:BCL2 protein, human